Ozelle Unveils Next-Generation AI-Driven Complete Blood Morphology Solution
Posted on 20 Nov 2025
Ozelle is unveiling its next-generation AI + Complete Blood Morphology (CBM) solution at MEDICA 2025. The platform is an all-in-one diagnostic innovation that integrates hematology, biochemistry, and immunoassay in a single run. The new solution is designed to meet the growing demand for rapid, standardized diagnostic processes and introduces three major breakthroughs.
The first advancement centers on all-in-one flexible testing, which makes it possible to perform multiple assays in a single run in any configuration needed to support varied clinical demands. From infection typing to diabetes and thyroid-function panels, the system supports tiered testing and is suitable for a wide range of applications, including outpatient clinics and POCT environments.
The second breakthrough is Ozelle’s AI+CBM (AI-driven Complete Blood Morphology), which combines quantitative CBC parameters with AI-powered visual cell analysis. This enables automated detection of abnormal cells within six minutes and eliminates the need for manual microscopy in most routine cases.
The third key advancement is its simple, maintenance-free operation, featuring a one-click, fully automated workflow with single-use reagent kits. With no sample pre-treatment, no cold-chain storage, and a maintenance-free design, the system ensures ease of use and reliability in any clinical setting.
Beyond product innovation, Ozelle continues to advance an intelligent diagnostic ecosystem in which hematology, biochemistry, and immunology data merge under a unified AI framework, transforming fragmented workflows into continuous, data-driven care. “Our mission is to make expert-level morphology and intelligent diagnostics accessible to every laboratory, every clinic, every day,” states the Ozelle R&D Leadership Team.
Related Links:
Ozelle
